Andrea Tan

Stock Analyst at Goldman Sachs

(1.01)
# 3,496
Out of 4,765 analysts
41
Total ratings
37.5%
Success rate
-11.23%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Andrea Tan

Iovance Biotherapeutics
Mar 3, 2025
Maintains: Buy
Price Target: $22$19
Current: $3.52
Upside: +439.77%
Day One Biopharmaceuticals
Feb 10, 2025
Maintains: Buy
Price Target: $48$43
Current: $8.70
Upside: +394.25%
Tarsus Pharmaceuticals
Nov 15, 2024
Maintains: Neutral
Price Target: $36$41
Current: $46.47
Upside: -11.77%
Insmed
Jul 10, 2024
Maintains: Buy
Price Target: $74$102
Current: $75.07
Upside: +35.87%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23$6
Current: $3.51
Upside: +70.94%
Arrowhead Pharmaceuticals
Jun 5, 2024
Initiates: Neutral
Price Target: $31
Current: $15.07
Upside: +105.71%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3$2
Current: $0.27
Upside: +635.29%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $3.45
Upside: -42.03%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $177.37
Upside: -9.79%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27$24
Current: $2.40
Upside: +900.00%
Maintains: Sell
Price Target: $10$4
Current: $0.94
Upside: +325.53%
Maintains: Buy
Price Target: $178$375
Current: $323.02
Upside: +16.09%
Initiates: Sell
Price Target: $13
Current: $6.15
Upside: +111.38%
Maintains: Neutral
Price Target: $6$4
Current: $0.82
Upside: +389.18%